Author Archive for Insider Scoop

Why Caesars And Eldorado Are Trading Higher Today

Courtesy of Benzinga

Why Caesars And Eldorado Are Trading Higher Today

Caesars Entertainment Corporation (NASDAQ: CZR) and Eldorado Resorts (NASDAQ: ERI) shares are trading higher on Tuesday. A source told CNBC the merger between the two companies should be completed in June.

The casino sector faces headwinds due to the coronavirus and decreased travel and leisure demand.

“There has been some speculation that the massive disruption in the casino sector due to the pandemic would slow down the regulatory review of the deal,” according to Seeking Alpha.

Eldorado Resorts shares were trading up 21% at $14.58 on Tuesday. The stock has a 52-week high of $70.74 and a 52-week low of $6.02.

Caesars Entertainment shares were trading up 4.05% at $6.68. The stock has a 52-week range between $14.74 and $3.22.

Related Links:

Caesars Entertainment To Sell Rio Casino Business For $516.3M

Twin River Worldwide Will Buy 2 Casinos From Eldorado Resorts For $230M





Why SiriusXM’s Stock Is Trading Higher Today

Courtesy of Benzinga

Why SiriusXM's Stock Is Trading Higher Today

SiriusXM Holdings Inc. (NASDAQ: SIRI) shares are trading higher on Tuesday after receiving an upgrade.

Citigroup analyst Jason Bazinet upgraded the stock from Neutral to Buy and announced a price target of $5.90.

See Also: Sirius XM Invests $75M In SoundCloud

SiriusXM is an American broadcasting company headquartered in Midtown Manhattan, New York City that provides satellite radio and online radio services operating in the U.S.

Sirius XM shares were trading up 4.57% at $5.03 on Tuesday. The stock has a 52-week high of $7.40 and a 52-week low of $4.11.

Latest Ratings for SIRI

Date Firm Action From To
Mar 2020 Citigroup Upgrades Neutral Buy
Mar 2020 B. Riley FBR Maintains Buy
Feb 2020 Credit Suisse Downgrades Outperform Neutral

View More Analyst Ratings for SIRI


View the Latest Analyst Ratings





Amazon Warehouse Workers Plan Monday Walkout To Protest Lack Of Coronavirus Protection

Courtesy of Benzinga

Amazon Warehouse Workers Plan Monday Walkout To Protest Lack Of Coronavirus Protection

Amazon.com Inc.’s (NASDAQ: AMZN) workers at the company’s Staten Island warehouse are planning a mass walkout on Monday to protest against what they call a lack of protection provided during the novel coronavirus (COVID-19) pandemic.

What Happened

Anywhere between 50 to 200 workers are expected to participate in the walkout, Christian Smalls, as assistant manager at the New York facility, who is in charge of the protest, told CNN.

The workers are demanding for the warehouse to be closed and sanitized, and be paid fully for the time that the warehouse remains closed, Smalls said.

According to Smalls, Amazon kept the warehouse open with inadequate measures, despite a worker at the facility testing positive for COVID-19.

As reported by CNN, Smalls further alleged that more workers have tested positive than Amazon has publicly admitted.

“We believe direct communication is the best avenue to discuss feedback, and our teams onsite are speaking directly with employees each day to hear their questions and discuss options that are available in this ever changing environment,” an Amazon spokesperson told CNN, adding that the company is conducting daily temperature checks at the facility to protect workers.

Smalls said that he sought the help of the warehouse general manager before calling for the walkout, but didn’t get a helpful response. He further told CNN that he also reached to the Centers for Disease Control and New York Governor Andrew Cuomo’s office, but is yet to receive a response.

Why It Matters

Amazon had announced earlier this month that all employees whose job allows them to work from home should do so, but those working in warehouses and deliveries are required to be present physically at the centers for their work.

The company said it would provide two weeks of pay to anyone who has been diagnosed with coronavirus or quarantined by authorities as a suspected case.

In addition, the workers can get up for two weeks of additional pay if they have tested positive.

Those employees who haven’t been infected and quarantined have the option of unpaid leave with no disciplinary action.

Coronavirus cases have been confirmed at least 11 Amazon facilities across the U.S., including at another New York warehouse in Queens, raising fears among other workers of being exposed to the


continue reading





90 Biggest Movers From Friday

Courtesy of Benzinga

Gainers

  • BIO-key International, Inc. (NASDAQ: BKYI) shares jumped 91.8% to close at $1.05 on Friday after the company won a $45 million contract for its biometric software and hardware solutions.
  • Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) rose 51.2% to close at $3.84.
  • THL Credit, Inc. (NASDAQ: TCRD) gained 48.5% to close at $2.94 after gaining over 17% on Thursday.
  • NexPoint Real Estate Finance, Inc. (NYSE: NREF) rose 33.9% to close at $9.45.
  • Green Plains Partners LP (NASDAQ: GPP) gained 33.5% to close at $7.10.
  • Bio-Path Holdings, Inc. (NASDAQ: BPTH) rose 32.3% to close at $5.07.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) gained 32% to close at $7.13.
  • Eton Pharmaceuticals, Inc. (NASDAQ: ETON) climbed 31% to close at $4.36 after the company reported the purchase of US marketing rights to pediatric orphan drug Alkindi Sprinkle.
  • Nesco Holdings, Inc. (NYSE: NSCO) gained 25% to close at $3.55.
  • Eyenovia, Inc. (NASDAQ: EYEN) climbed 23.9% to close at $2.85.
  • Ares Commercial Real Estate Corporation (NYSE: ACRE) surged 21.2% to close at $8.79.
  • Alpha Pro Tech, Ltd. (NYSE: APT) surged 19.8% to close at $11.20.
  • CooTek (Cayman) Inc. (NYSE: CTK) gained 18.9% to close at $6.85.
  • Sirius International Insurance Group, Ltd. (NASDAQ: SG) rose 18.7% to close at $8.50.
  • Nautilus, Inc. (NYSE: NLS) gained 18.6% to close at $2.80.
  • Navios Maritime Acquisition Corporation (NYSE: NNA) surged 16.7% to close at $4.40.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) gained 16.4% to close at $8.32 amid growing global coronavirus fears, as the company is working on a coronavirus vaccine.
  • Sharps Compliance Corp. (NASDAQ: SMED) rose 16.1% to close at $6.77.
  • Tilray, Inc. (NASDAQ: TLRY) climbed 15.2% to close at $9.10 on continued momentum from recent sessions.
  • Sutter Rock Capital Corp. (NASDAQ: SSSS) gained 15.2% to close at $5.67.
  • BBQ Holdings, Inc. (NYSE: BBQ) rose 14.8% to close at $2.40.
  • KKR Real Estate Finance Trust Inc. (NYSE: KREF) gained 14.8% to close at $15.57.
  • SmileDirectClub, Inc. (NASDAQ: SDC) rose 13.4% to close at $5.50 after the company’s company announced plans to produce face shields for medical personnel amidst COVID-19 pandemic.


continue reading





Earnings Scheduled For March 30, 2020

Courtesy of Benzinga

Earnings Scheduled For March 30, 2020

Companies Reporting Before The Bell

  • Cal-Maine Foods, Inc. (NASDAQ: CALM) is projected to report quarterly earnings at $0.17 per share on revenue of $338.08 million.
  • HEXO Corp. (NYSE: HEXO) is estimated to report quarterly loss at $0.06 per share on revenue of $12.21 million.
  • China Yuchai International Limited (NYSE: CYD) is projected to report quarterly earnings at $2.23 per share on revenue of $4.24 billion.
  • Greenlane Holdings, Inc. (NASDAQ: GNLN) is estimated to report quarterly loss at $0.07 per share on revenue of $38.36 million.
  • P&F Industries, Inc. (NASDAQ: PFIN) is expected to report earnings for its fourth quarter.
  • The LGL Group, Inc. (NYSE: LGL) is projected to report earnings for its fourth quarter.

Companies Reporting After The Bell

  • RH (NYSE: RH) is estimated to post quarterly earnings at $3.59 per share on revenue of $708.87 million.
  • Venus Concept Inc. (NASDAQ: VERO) is expected to post quarterly loss at $1.12 per share on revenue of $32.71 million.
  • Village Farms International, Inc. (NASDAQ: VFF) is estimated to post quarterly earnings at $0.03 per share on revenue of $41.96 million.
  • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) is projected to post quarterly loss at $0.44 per share on revenue of $23.46 million.
  • Aptinyx Inc. (NASDAQ: APTX) is expected to post quarterly loss at $0.56 per share on revenue of $1.02 million.
  • Neovasc Inc. (NASDAQ: NVCN) is estimated to post quarterly loss at $0.05 per share on revenue of $1.16 million.
  • RumbleON, Inc. (NASDAQ: RMBL) is projected to post quarterly loss at $0.34 per share on revenue of $141.83 million.
  • RYB Education, Inc. (NYSE: RYB) is estimated to post quarterly earnings at $0.05 per share.
  • CUI Global, Inc. (NASDAQ: CUI) is projected to post quarterly loss at $0.11 per share on revenue of $5.95 million.
  • IZEA Worldwide, Inc. (NASDAQ: IZEA) is expected to post quarterly loss at $0.04 per share on revenue of $4.32 million.
  • Alpine Immune Sciences, Inc. (NASDAQ: ALPN) is estimated to


continue reading





HQ Trivia Receives Anonymous Investment, Relaunches Games

Courtesy of Benzinga

HQ Trivia Receives Anonymous Investment, Relaunches Games

Mobile quiz app HQ Trivia made a comeback on Sunday night as it received funding from an unknown investor.

What Happened

In mid-February, New-York based HQ Trivia ran out of funds and shut down its operations of interactive quiz shows, which had become a massive hit in 2017. 

In December 2018, after its founding CEO Colin Kroll died, it encountered many financial problems. Rus Yusupov, co-founder, tried to keep the company alive but could not manage it and laid off staff amid declining users and rising costs.

The app, which conducted games twice a day had almost 2 million players at its peak, reported The Telegraph. It would allow players to win money by answering quiz questions against the clock.

Earlier in 2020, HQ had progressed in buyout talks with media company Whistle for almost $20 million, but the deal did not go through.

Next Steps

HQ Trivia said that the company would donate $100,000 to World Central Kitchen, the charity that makes food for people in emergency zones, such as those affected by wildfires or the coronavirus.





18 Healthcare Stocks Moving In Monday’s Pre-Market Session

Courtesy of Benzinga

Gainers

Plus Therapeutics, Inc. (NASDAQ:PSTV) stock surged 38.89% to $2 during Monday’s pre-market session.

Owens & Minor, Inc. (NYSE:OMI) stock moved upwards by 30.91% to $7.20. The most recent rating by Baird, on Jan 21, is at Outperform, with a price target of $9.

Kitov Pharma, Inc. (NASDAQ:KTOV) shares moved upwards by 16.62% to $0.40.

Allied Healthcare Prods, Inc. (NASDAQ:AHPI) stock moved upwards by 15.74% to $20.

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares surged 11.11% to $3.40.

CHF Solutions, Inc. (NASDAQ:CHFS) shares surged 10.64% to $0.52.

Altimmune, Inc. (NASDAQ:ALT) shares increased by 9.47% to $3.12.

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) shares increased by 9.24% to $3.25. The most recent rating by SunTrust Robinson Humphrey, on Feb 27, is at Buy, with a price target of $5.

Abbott Laboratories, Inc. (NYSE:ABT) shares surged 8.33% to $80.80. The most recent rating by Morgan Stanley, on Mar 27, is at Overweight, with a price target of $96.

Aytu BioScience, Inc. (NASDAQ:AYTU) stock increased by 8.24% to $1.97.

Losers

Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares decreased by 21.92% to $49.40 during Monday’s pre-market session.

Co-Diagnostics, Inc. (NASDAQ:CODX) stock declined 10.16% to $8.22. According to the most recent rating by Maxim Group, on Mar 3, the current rating is at Hold.

Guardion Health Sciences, Inc. (NASDAQ:GHSI) stock declined 8.89% to $0.41.

Zosano Pharma, Inc. (NASDAQ:ZSAN) stock decreased by 8.84% to $0.51. The most recent rating by BTIG, on Mar 27, is at Buy, with a price target of $7.

Cocrystal Pharma, Inc. (NASDAQ:COCP) shares declined 8.43% to $0.70.

Onconova Therapeutics, Inc. (NASDAQ:ONTX) shares decreased by 7.63% to $0.30.

Abeona Therapeutics, Inc. (NASDAQ:ABEO) stock declined 6.80% to $1.92. The most recent rating by RBC Capital, on Mar 18, is at Outperform, with a price target of $11.

Tilray, Inc. (NASDAQ:TLRY) stock fell 5.16% to $8.63. The most recent rating by Cantor Fitzgerald, on Mar 16, is at Neutral, with a price target of $5.

 

Related Articles (OMI + PSTV)


continue reading





With Everybody Stuck At Home, Investor Conferences Are Going Virtual

Courtesy of Benzinga

With Everybody Stuck At Home, Investor Conferences Are Going Virtual

With the world at a COVID-19-induced standstill, many conference organizers have either gone online (Benzinga is one of them) or had to cancel upcoming events altogether. There is no clear timetable on how much longer we will be in this state.

Publicly traded companies are already limited in when they can provide business updates because of quiet periods ahead of quarterly earnings reports. So at a time when market uncertainty is at its highest, the window for companies looking to engage with investors is getting smaller.

“In the short term, from an issuer perspective, they’ve lost the opportunity to engage with investors,” said John Viglotti, senior vice president of corporate services, investor access at OTC Markets.

As a result of the rash of investor conference cancellations—investment bank conferences around the world are being canceled or postponed, as are Investor Days from companies like Target Corporation (NYSE: TGT), Berkshire Hathaway Inc. (NYSE: BRK-B), and United Airlines Holdings Inc (NASDAQ: UAL), to name a few. More companies have expressed an interest in participating in online conferences according to Jason Paltrowitz, executive vice president of corporate services at OTC Markets.

“If you think about it from the issuer perspective, companies are always looking to reach new investors. What we’re seeing with our virtual platforms is that because the traditional conferences are being shut down, we are seeing a tremendous amount of interest in this business.”

Virtual Investor Conferences, OTC Markets Group’s online-only investor conference series, has already hosted six conferences through March of this year, compared to 20 in all of 2019 and 10 the year before that (you can view the upcoming conference schedule here). The increased interest, Paltrowitz said, has come from participants throughout the conference ecosystem, including individual companies, conference organizers, and investor relations firms.

“If you ask any investor relations professional, they’d say that in the good times and the bad times you need to be out there telling your story,” he said. “Yes, there’s a crisis, but what are you doing to get out of it? Where are you positioning yourself in it? Are you able to ride out an economic downturn


continue reading





Why Axsome Shares Are Pulling Back After A Clinical Readout

Courtesy of Benzinga

Why Axsome Shares Are Pulling Back After A Clinical Readout

Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) — which skyrocketed 3,565% in 2019 thanks to a steady stream of positive clinical updates — were tanking Monday.

Axsome’s Mixed Results Trigger Investor Pullback

In a late-stage clinical readout, New York-based Axsome said AXS-05, its Phase 3 asset that is being evaluated for treatment-resistant depression, did not achieve the primary endpoint of statistically significant numerical improvement in the Montgomery-Asberg Depression Rating Scale, or MADRS at week six. 

AXS-05 showed mean reductions of 11.6 compared to 9.4 for the active comparator bupropion, according to the company. 

AXS-05 is an oral investigational NMDA receptor antagonist with multimodal activity.

The Phase 3 study dubbed STRIDE-1 was a double-blind, active-controlled, multicenter U.S. trial that evaluated 312 adult patients with confirmed TRD who had failed two or three prior treatments and were randomized to received either AXS-05 or 150mg of bupropion twice daily for six weeks.

The investigational candidate met key secondary endpoints: statistically significant improvement in symptoms of depression as early as Week 1, and for the six-week treatment week, improvement in cognitive functions and reduction in anxiety symptoms.

AXS-05 was well tolerated, with dizziness and nausea being the commonly reported adverse events and low rates of discontinuation due to adverse events, according to Axsome. 

What’s Next For Axsome 

Axsome said it intends to initiate a second Phase 3 trial of AXS-05 in patients with TRD in the third quarter of 2020. The company also said it plans to submit detailed study results for presentation at upcoming medical meetings and for publication.

The company said it remains on track to file an NDA in the fourth quarter for AXS-05 in the treatment of major depressive disorder, based on the previously completed positive GEMINI and ASCEND trials.

Axsome said results from the INTERCEPT Phase 3 trial of AXS-07 in the early treatment of migraine are imminent, while data from the ADVANCE-1 Phase 2/3 trial of AXS-05 in Alzheimer’s disease agitation is expected in early second quarter.

AXSM Price Action

The stock was down 11.53% at $55.98 at the time of publication Monday. 





‘Psyched’: Hawaii Considers Resolution For Shrooms, Champignon Eyes Ketamine Products

Courtesy of Benzinga

'Psyched': Hawaii Considers Resolution For Shrooms, Champignon Eyes Ketamine Products

Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry.

Champignon Brands Buys IP Company and Adds Ketamine and New Formulations To Its Portfolio

On March 19, Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF), a Canadian health and wellness company focused on the formulation and distribution of medicinal mushrooms products, acquired a new IP that will allow it to add Ketamine products to its portfolio.

The intellectual property addition comes from the acquisition of Novo Formulations Ltd., a biotechnology company working with ketamine, anaesthetics and adaptogenics, in a purpose-built GMP and pharmaceutical licensed facility in Quebec, Canada, and an accredited pharmacy in Ontario. The company is developing transdermal (topical), intranasal, sublingual, oral and suppository formulations.

Aside from adding Ketamine to its portfolio, Champignon will leverage Novo’s expertise into developing new formulations that could make psilocybin and MDMA products more readily available for consumers.

Hawaii Lawmakers Introduce Resolution To Study Psilocybin

Hawaii Legislature introduced a new set of resolutions aimed at studying the medicinal applications of psilocybin. The lawmakers aim to develop a plan that ensures the availability of the compound for adult patients across the state. 

The resolutions, introduced both in the state House and Senate, would create Medicinal Psilocybin Working Group to examine federal, state, and local laws and regulations for psilocybin; review medical, psychological, and scientific research; and analyze guidelines for medical professionals to prescribe the drug.

The group is expected to develop a long-term strategic plan that guarantees the availability of psilocybin or psilocybin-based products to adults over 21, along with a proposed piece of legislation that must be submitted before the convening of the 2022 Regular Session.

The resolution makes mention of a shortage of mental health professionals in the Aloha State, which call for a need to explore novel, innovative and safe solutions for psychological and psychiatric treatment.

Mindbloom Offers Ketamine Treatment Through Virtual Consultations Amid Social Distancing

On March 24, New York-based mental health company Mindbloom announced it will be offering remote therapy sessions using ketamine-assisted treatment for home-bound New Yorkers, in light of the COVID-19 pandemic quarantines.


continue reading





 
 
 

Phil's Favorites

Johnson & Johnson vaccine suspension - what this means for you

 

Johnson & Johnson vaccine suspension – what this means for you

Vials of the Johnson & Johnson vaccine to prevent COVID-19. The use of this particular vaccine has been halted temporarily. Justin Tallis/AFP via Getty Images

Courtesy of William Petri, University of Virginia

The Centers for Disease Control and Prevention and the Food and Drug Administration on April 13, 2021 halted use of the one-dose Johnson & Johnson COVID-19 vaccine that has been given to 6.8 million people in the U.S. The pause is...



more from Ilene

Biotech/COVID-19

Johnson & Johnson vaccine suspension - what this means for you

 

Johnson & Johnson vaccine suspension – what this means for you

Vials of the Johnson & Johnson vaccine to prevent COVID-19. The use of this particular vaccine has been halted temporarily. Justin Tallis/AFP via Getty Images

Courtesy of William Petri, University of Virginia

The Centers for Disease Control and Prevention and the Food and Drug Administration on April 13, 2021 halted use of the one-dose Johnson & Johnson COVID-19 vaccine that has been given to 6.8 million people in the U.S. The pause is...



more from Biotech/COVID-19

ValueWalk

UK's First-Time Buyers See House Prices Climb

By Jacob Wolinsky. Originally published at ValueWalk.

First-time buyers paying as much as £73k more to get on the ladder since the market reopened

Q1 2021 hedge fund letters, conferences and more

The Climbing Cost Of Houses For First Time Buyers

Research by the new build snagging and defect management experts, ...



more from ValueWalk

Zero Hedge

Trading Bonds In Venezuela? Bring A Gunman And Cash

Courtesy of ZeroHedge View original post here.

The Venezuelan bond market - described by Bloomberg as one of the 'tiniest and almost certainly the most primitive' in the world - is also one of the most dangerous.

Based in Caracas where Nicolas Maduro's socialist government is 'ever so slowly freeing up the battered economy' for capitalistic endeavors, the US dollar has become the defacto currency. Yet, there's no electronic method to electronically transfer USD from one bank to another - which mean...



more from Tyler

Digital Currencies

Coinbase Sets Reference Price At $250, Well Below Last Private Market Trade

Courtesy of ZeroHedge

Ahead of tomorrow's much-anticipated direct listing of massive crypto-exchange Coinbase, Nasdaq has just announced the company's so-called Reference Price at $250.

On April 14, 2021, the Class A common stock of Coinbase Global, Inc. is expected to list on Nasdaq through a Direct Listing using the ticker “COIN”.

Because this security has not previously traded on any listing market and has no prior day's closing price, Regulation SHO Rule 201 will not apply to the security until its second day of trading on Nasdaq.

As a Direct Listing, COIN will be in a regulatory halt until ...



more from Bitcoin

Kimble Charting Solutions

Semiconductor Red Hot Performance Tests 20-Year Breakout Level

Courtesy of Chris Kimble

Will the “Red Hot” semiconductor index cool off or get even hotter due to the shortage of chips?

This chart looks at the Semiconductor Index on a monthly basis over the past quarter-century. No doubt the trend is up as it has created a series of higher lows and higher highs since 2009.

Fibonacci extension levels were applied to the 1996 lows and the 2000 highs. Currently, the index is testing the 261% extension level, while at the top of the rising channel as momentum is at the highest level since the 2000 highs.

The rare chip shortage coul...



more from Kimble C.S.

Chart School

RTT browsing latest..

Courtesy of Read the Ticker

Please review a collection of WWW browsing results. The information here is delayed by a few months, members get the most recent content.



Date Found: Saturday, 31 October 2020, 07:10:55 PM

Click for popup. Clear your browser cache if image is not showing.


Comment: Black line could chase the orange line..higher asset prices for 2021. Post US election pop!



Date Found: Saturday, 31 October 2020, 11:32:25 PM

Click for popup. Clear your browser cache if image is not showing.


Comment: Just like gold ...


...

more from Chart School

Politics

For autocrats like Vladimir Putin, ruthless repression is often a winning way to stay in power

 

For autocrats like Vladimir Putin, ruthless repression is often a winning way to stay in power

Russian police officers beat people protesting the jailing of opposition leader Alexei Navalny, Jan. 23, 2021 in Moscow. Mikhail Svetlov/Getty Images)

Courtesy of Shelley Inglis, University of Dayton

Russian dissident Alexei Navalny, sick with a cough and ...



more from Politics

Mapping The Market

Suez Canal: Critical Waterway Comes to a Halt

 

Suez Canal: Critical Waterway Comes to a Halt

Courtesy of Marcus Lu, Visual Capitalist

The Suez Canal: A Critical Waterway Comes to a Halt

On March 23, 2021, a massive ship named Ever Given became lodged in the Suez Canal, completely blocking traffic in both directions. According to the Suez Canal Authority, the 1,312 foot long (400 m) container ship ran aground during a sandstorm that caused low visibility, impacting the ship’s navigation. The vessel is owned by Taiwanese shipping firm, Evergreen Marine.

With over 2...



more from M.T.M.

Promotions

Phil's Stock World's Weekly Webinar - March 10, 2021

Don't miss our latest weekly webinar! 

Join us at PSW for LIVE Webinars every Wednesday afternoon at 1:00 PM EST.

Phil's Stock World's Weekly Webinar – March 10, 2021

 

Major Topics:

00:00:01 - EIA Petroleum Status Report
00:04:42 - Crude Oil WTI
00:12:52 - COVID-19 Update
00:22:08 - Bonds and Borrowed Funds | S&P 500
00:45:28 - COVID-19 Vaccination
00:48:32 - Trading Techniques
00:50:34 - PBR
00:50:43 - LYG
00:50:48 - More Trading Techniques
00:52:59 - Chinese Hacks Microsoft's E...



more from Promotions

The Technical Traders

Adaptive Fibonacci Price Modeling System Suggests Market Peak May Be Near

Courtesy of Technical Traders

Our Adaptive Fibonacci Price Modeling system is suggesting a moderate price peak may be already setting up in the NASDAQ while the Dow Jones, S&P500, and Transportation Index continue to rally beyond the projected Fibonacci Price Expansion Levels.  This indicates that capital may be shifting away from the already lofty Technology sector and into Basic Materials, Financials, Energy, Consumer Staples, Utilities, as well as other sectors.

This type of a structural market shift indicates a move away from speculation and towards Blue Chip returns. It suggests traders and investors are expecting the US consumer to come back strong (or at least hold up the market at...



more from Tech. Traders

Lee's Free Thinking

Texas, Florida, Arizona, Georgia - The Branch COVIDIANS Are Still Burning Down the House

 

Texas, Florida, Arizona, Georgia – The Branch COVIDIANS Are Still Burning Down the House

Courtesy of Lee Adler, WallStreetExaminer 

The numbers of new cases in some of the hardest hit COVID19 states have started to plateau, or even decline, over the past few days. A few pundits have noted it and concluded that it was a hopeful sign. 

Is it real or is something else going on? Like a restriction in the numbers of tests, or simply the inability to test enough, or are some people simply giving up on getting tested? Because as we all know from our dear leader, the less testing, the less...



more from Lee

Insider Scoop

Economic Data Scheduled For Friday

Courtesy of Benzinga

  • Data on nonfarm payrolls and unemployment rate for March will be released at 8:30 a.m. ET.
  • US Services Purchasing Managers' Index for March is scheduled for release at 9:45 a.m. ET.
  • The ISM's non-manufacturing index for March will be released at 10:00 a.m. ET.
  • The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
...

http://www.insidercow.com/ more from Insider





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. Contact Ilene to learn about our affiliate and content sharing programs.